By Drug Target Review2023-09-04T09:46:25
Researchers have developed a novel based CRISPR-free base editing system named CyDENT, which enables precise base editing.
Already a member? Sign in
By highlighting cutting-edge research and its practical applications, Drug Target Review enables readers to make decisions that accelerate innovation, translate discoveries into therapies, and create tangible benefits for patients worldwide.
By becoming a member you join a connected and collaborative community driving the industry forward. Member benefits include:
2023-09-27T13:56:39
Sponsored by Euretos
2024-01-19T07:40:55
Sponsored by Euretos
2023-03-30T12:35:58
Sponsored by Sartorius
2025-08-05T13:42:00
Sponsored by ICON plc., By Drug Target Review
2023-03-23T14:46:21
Sponsored by Bio-Techne
Site powered by Webvision Cloud